Multitarget Antileukemic Effects of Metformin in Myeloproliferative Neoplasm Cells: Inhibition of JAK2/STAT Signaling and Mitochondrial Activity

被引：0
|
作者：
Machado-Neto, Joao Agostinho [1 ]
Fenerich, Bruna Alves [1 ]
Scopim-Ribeiro, Renata [1 ]
Dechandt, Carlos Roberto Porto [2 ]
Alves, Ana Paula Nunes Rodrigues [1 ]
Fernandes, Jaqueline Cristina [1 ]
Scheucher, Priscila Santos [1 ]
Simoes, Belinda Pinto [1 ]
Alberici, Luciane Carla [2 ]
Pontes, Lorena Lobo de Figueiredo [1 ]
Rego, Eduardo Magalhaes [1 ]
Traina, Fabiola [1 ]
机构：
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, Dept Phys & Chem, Ribeirao Preto, Brazil
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1960.1960
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1960
引用
收藏
页数：4
相关论文
共 50 条
  • [1] AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells
    Pearson, Stella
    Blance, Rognvald
    Somervaille, Tim C. P.
    Whetton, Anthony D.
    Pierce, Andrew
    HEMASPHERE, 2019, 3 (03):
  • [2] Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm
    Yin, Li-hui
    Zheng, Xiao-qun
    Li, Hai-ying
    Bi, Lai-xi
    Shi, Yi-fen
    Ye, Ai-fang
    Wu, Jian-bo
    Gao, Shen-meng
    LEUKEMIA RESEARCH, 2015, 39 (04) : 471 - 478
  • [3] JAK2 inhibition has different therapeutic effects according to myeloproliferative neoplasm development in mice
    Debeurme, Franck
    Lacout, Catherine
    Moratal, Claudine
    Bagley, Rebecca G.
    Vainchenker, William
    Adrian, Francisco
    Villeval, Jean-Luc
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (11) : 2564 - 2574
  • [4] Formononetin acts synergistically with a JAK2 inhibitor to suppress growth in myeloproliferative neoplasm by inhibiting JAK/STAT3 signaling pathway
    Jiang, Huijun
    Fan, Zaijing
    Li, Jiashan
    Zheng, Xiaoqun
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (06) : 1155 - 1160
  • [5] Inhibition of Both Jak2 and STAT5 Enhances Toxicity to Myeloproliferative Cells.
    Bar-Natan, Michal
    Nelson, Erik A.
    Walker, Sarah R.
    Barrett, Rosemary
    Frank, David A.
    BLOOD, 2009, 114 (22) : 756 - 756
  • [6] Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells
    M Bar-Natan
    E A Nelson
    S R Walker
    Y Kuang
    R J Distel
    D A Frank
    Leukemia, 2012, 26 : 1407 - 1410
  • [7] Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells
    Bar-Natan, M.
    Nelson, E. A.
    Walker, S. R.
    Kuang, Y.
    Distel, R. J.
    Frank, D. A.
    LEUKEMIA, 2012, 26 (06) : 1407 - 1410
  • [8] Activation of dendritic cells via inhibition of Jak2/STAT3 signaling
    Nefedova, Y
    Cheng, PY
    Gilkes, D
    Blaskovich, M
    Beg, AA
    Sebti, SM
    Gabrilovich, DI
    JOURNAL OF IMMUNOLOGY, 2005, 175 (07): : 4338 - 4346
  • [9] JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
    McKenney, Anna Sophia
    N., Allison
    Somasundara, Amritha Varshini Hanasoge
    Spitzer, Barbara
    Intlekofer, Andrew M.
    Ahn, Jihae
    Shank, Kaitlyn
    Rapaport, Franck T.
    Patel, Minal A.
    Papalexi, Efthymia
    Shih, Alan H.
    Chiu, April
    Freinkman, Elizaveta
    Akbay, Esra A.
    Steadman, Mya
    Nagaraja, Raj
    Yen, Katharine
    Teruya-Feldstein, Julie
    Wong, Kwok-Kin
    Rampal, Raajit
    Vander Heiden, Matthew G.
    Thompson, Craig B.
    Levine, Ross L.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02): : 789 - 804
  • [10] Inhibition of JAK2/STAT signaling by degrasyn through a novel mechanism.
    Kapuria, Vaibhav
    Bartholomeusz, Geoffrey
    Bommann, William
    Kong, Ling Y.
    Talpaz, Moshe
    Nicholas, J. Donato
    BLOOD, 2006, 108 (11) : 977A - 977A
12345